Term ends Oct 26, 2037 · Low confidence
20-year base term ends Oct 26, 2037
Oct 26, 2017
Oct 26, 2037
Sep 21, 2021
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 26, 2017, when application PCT/US2017/058610, the earliest non-provisional in its chain, was filed (this one was filed Apr 16, 2021); a parent in its chain could not be resolved (the next row) | Oct 26, 2037 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,013,770, US 11,058,728, US 11,141,438, US 11,179,419, US 11,202,803) | resolves to Oct 26, 2037, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 26, 2037 | Low confidence |
This family
| Application PCT/US2017/058610 | PCT application no patent term | no patent term |
| US 11,026,974 | In force Oct 2037 | Oct 2037 |
| US 10,517,894 | In force Oct 2037 | Oct 2037 |
| US 11,058,728 | In force Oct 2037 | Oct 2037 |
| US 11,179,419 | In force Oct 2037 | Oct 2037 |
| US 11,123,371 | this patent Oct 2037 | Oct 2037 |
| US 11,141,438 | In force Oct 2037 | Oct 2037 |
| US 11,304,980 | In force no later than Oct 2037 | no later than Oct 2037 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 27, 2022 Reel 61567, frame 271 | Frank, Ian; Lotze, Michael T. | Lion Biotechnologies, Inc. | Assignment of Assignor's Interest |
| Oct 27, 2022 Reel 61793, frame 296 | Lion Biotechnologies, Inc. | Iovance Biotherapeutics, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 11,013,770, US 11,058,728, US 11,141,438, US 11,179,419, US 11,202,803, ends no earlier than this term, so it caps nothing.